In Vitro Activity of Amphotericin B Against Candida lusitaniae Clinical Isolates

被引：0
|
作者：
Prigitano, A. [1 ]
Biraghi, E. [1 ]
Pozzi, C. [2 ]
Viviani, M. A. [1 ]
Tortorano, A. M. [1 ]
机构：
[1] Univ Milan, Dipartimento Sanita Pubbl Microbiol Virol, I-20133 Milan, Italy
[2] Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Microbiol Lab, Milan, Italy
来源：
JOURNAL OF CHEMOTHERAPY | 2010年 / 22卷 / 01期
关键词：
ASPERGILLUS-FUMIGATUS; RESISTANCE; SUSCEPTIBILITY; EPIDEMIOLOGY; ALBICANS;
D O I：
10.1179/joc.2010.22.1.71
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [1] In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined
    Szabo, Zsuzsanna
    Soczo, Georgina
    Miszti, Cecilia
    Hermann, P.
    Rozgonyi, F.
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2008, 55 (01) : 53 - 61
  • [2] Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B
    Singh, J
    Rimek, D
    Kappe, R
    [J]. MYCOSES, 2006, 49 (02) : 96 - 103
  • [3] High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance
    Yoon, SA
    Vazquez, JA
    Steffan, PE
    Sobel, JD
    Akins, RA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 836 - 845
  • [4] In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.
    Serena, Carolina
    Marine, Marcal
    Quindos, Guillermo
    Carrillo, Alfonso J.
    Cano, J. F.
    Pastor, F. Javier
    Guarro, Josep
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1529 - 1532
  • [5] In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates
    Oz, Yasemin
    Aksit, Filiz
    Kiraz, Nuri
    Kiremitci, Abdurrahman
    [J]. MIKROBIYOLOJI BULTENI, 2008, 42 (01): : 149 - 155
  • [6] In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates
    Arikan, S
    Ostrosky-Zeichner, L
    Lozano-Chiu, M
    Paetznick, V
    Gordon, D
    Wallace, T
    Rex, JH
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1406 - 1412
  • [7] Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest
    Peyron, F
    Favel, A
    Michel-Nguyen, A
    Gilly, M
    Regli, P
    Bolmström, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 339 - 342
  • [8] Comparative In Vitro Antifungal Susceptibility Activity of Amphotericin B Versus Amphotericin B Methyl Ester Against Candida albicans Ocular Isolates
    Thanathanee, Onsiri
    Miller, Darlene
    Ringel, David M.
    Schaffner, Carl P.
    Alfonso, Eduardo C.
    O'Brien, Terrence P.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 589 - 592
  • [9] In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans
    Barchiesi, F
    Di Francesco, LF
    Compagnucci, P
    Arzeni, D
    Giacometti, A
    Scalise, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 59 - 65
  • [10] In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
    de-la-Fuente, Inigo
    Guridi, Andrea
    Jauregizar, Nerea
    Eraso, Elena
    Quindos, Guillermo
    Sevillano, Elena
    [J]. JOURNAL OF FUNGI, 2023, 9 (06)
12345